Signals, Powered By EquityPandit
Dr Reddy’s Laboratories has received Establishment Inspection Report (EIR), for its Miyapur facility, Hyderabad, Telangana.
The Custom Pharmaceutical Services facility, of Dr Reddy’s Laboratories at the company’s Technology Development Center (TDC-1) in Hyderabad, has received Establishment Inspection Report from the US Food and Drug Administration.
The USFDA has completed the audit of Miyapur facility in September with zero observations.
